LCN10: A Protein Associated with Disease Development and Progression

Target Name: LCN10

NCBI ID: G414332

LCN10

LCN10: A Protein Associated with Disease Development and Progression

LCN10, also known as LCN10 variant 1, is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the laminin family of proteins, which are involved in cell-cell adhesion and other physiological processes.

While LCN10 is not a well-known protein by itself, its presence and expression have been implicated in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This has led to renewed interest in LCN10 as a potential drug target or biomarker.

One of the key features of LCN10 is its ability to interact with other proteins, particularly those involved in the development and progression of cancer. Several studies have shown that LCN10 can interact with factors such as the transcription factor NF-kappa-B, which is involved in cancer growth and progression.

Additionally, LCN10 has been shown to play a role in the regulation of cell-cell adhesion, which is a critical process involved in the development and maintenance of tissues and organs. This is important because many diseases, including cancer, are characterized by disruptions in cell-cell adhesion that allow cells to migrate and invade other tissues.

Another potential mechanism by which LCN10 may contribute to the development and progression of disease is its role in the regulation of inflammation. Several studies have shown that LCN10 is involved in the regulation of inflammation at the tissue level, and that its expression is associated with the production of pro-inflammatory cytokines.

These findings have led some researchers to speculate that LCN10 may be a potential drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In particular, because LCN10 has been shown to interact with a wide range of proteins involved in the development and progression of these diseases, it may be a useful target for small molecules or other therapeutic compounds that can modulate its expression and activity.

While more research is needed to fully understand the role of LCN10 in disease, there is already evidence that its expression and activity are closely associated with the development and progression of many diseases. As such, LCN10 is a promising candidate for further study as a potential drug target or biomarker.

Protein Name: Lipocalin 10

Functions: May play a role in male fertility. May act as a retinoid carrier protein within the epididymis

The "LCN10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LCN10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets